Symptomatic treatment of cough reflex and non-productive cough in inflammatory disorders of the respiratory tract due to infection or other causes, smoker’s cough. It is effective in suppression of irritative cough during or after surgical, endoscopic, radiological or thoracentesis procedures. Irritative cough after endotracheal intubation or postoperative.
Much higher therapeutic adherence
Very wide antibiotic spectrum of action
Activity against Neisseria meningitidis.
Used to treat multidrug-resistant.
Better pharmacokinetic profile.
Longer half-life than Tetracycline.
FDA and European approval for the treatment of infections.
Low development of resistance in bacteria.
Coated tablets:
40 mg
Syrup:
20 mg/5 ml
USD global market sales in 2023
consumed globally
Lorem ipsum solor
PATENT PROTECTION